BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10371648)

  • 1. The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset.
    Smith AG; Neill JC; Costall B
    Pharmacol Biochem Behav; 1999 Jun; 63(2):201-11. PubMed ID: 10371648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys.
    Lee B; Groman S; London ED; Jentsch JD
    Neuropsychopharmacology; 2007 Oct; 32(10):2125-34. PubMed ID: 17299511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE; Hood CA; Heidema AM
    Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dopamine D3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog.
    Yoshida N; Yoshikawa T; Hosoki K
    Life Sci; 1995; 57(21):PL347-50. PubMed ID: 7475938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.
    Depoortere R; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 2000 Jan; 65(1):31-4. PubMed ID: 10638632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ; Girardon S; Monneyron S; Dekeyne A
    Neuropharmacology; 2000 Feb; 39(4):586-98. PubMed ID: 10728880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD; Rodefer JS; Picker MJ
    Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior.
    Boulougouris V; Castañé A; Robbins TW
    Psychopharmacology (Berl); 2009 Mar; 202(4):611-20. PubMed ID: 18836703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
    Boulay D; Depoortere R; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
    Varty GB; Higgins GA
    Behav Pharmacol; 1998 Sep; 9(5-6):445-55. PubMed ID: 9832930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
    Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
    Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the dopamine D3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processes in mice.
    Ukai M; Tanaka T; Kameyama T
    Eur J Pharmacol; 1997 Apr; 324(2-3):147-51. PubMed ID: 9145765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors.
    Sanger DJ; Depoortere R; Perrault G
    Psychopharmacology (Berl); 1997 Apr; 130(4):387-95. PubMed ID: 9160856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dopamine D3 receptor ligand 7-OH-DPAT on male rat ejaculatory behavior.
    Ahlenius S; Larsson K
    Pharmacol Biochem Behav; 1995; 51(2-3):545-7. PubMed ID: 7667384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.